Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Roche Building Fully Functional R&D Center

publication date: Oct 31, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Roche will build a second R&D center in China, spending $100 million to create the first fully functional China clinical drug R&D center that is owned by a multinational pharmaceutical company. Until now, Roche, like many other big pharmas, has had an R&D emplacement that specializes only in specific areas of the entire R&D development path. The new center will allow Roche to bring a drug candidate to China and leave the new R&D center responsible for all the work necessary to take the drug candidate through the regulatory process.  More details...

Stock Symbol: (OTCBB: RHBBY)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners